HRA003138
Title:
Precision medicine of lung cancer using molecular probes in clinical translational study
Release date:
2022-09-26
Description:
our major aim of the study is to identify the subset of patients who may benefit from EGFR-TKIs therapy, and hence to design appropriate treatment strategies for optimized clinical outcome. Specifically, the biopsied samples of lung cancer patients are subjected to quantitative detection of EGFR mutations (L858R, 19del) using the fluorescent probe HX103 and FACS analysis. Combined with the results from gene sequencing and HX103 labeling, it will allow us to rapid and accurate determine EGFR mutations in lung cancer patients.
Data Accessibility:   
Open access
BioProject:
Study type:
Disease Study
Disease name:
lung cancer
Dataset Download
MetaData:
Files:
Aspera Command Line:  Help   

 Note: HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client) or Asepra Command Line.

Individuals & samples
Files
Submitter:   Weimin Li / weimi003@scu.edu.cn
Organization:   Frontiers Science Center for Disease-related Molecular Networks, West China Hospital, Sichuan University, Chengdu, Sichuan, China
Submission date:   2022-09-25